MediPharm Labs Corp (FRA:MLZ)
€ 0.0352 0 (0%) Market Cap: 16.45 Mil Enterprise Value: 8.16 Mil PE Ratio: 0 PB Ratio: 0.55 GF Score: 0/100

Q3 2020 Medipharm Labs Corp Earnings Call Transcript

Nov 16, 2020 / 01:30PM GMT
Release Date Price: €0.346 (-26.38%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the MediPharm Labs third-quarter financial results earnings conference call. (Operator Instructions) Please be advised today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Laura Lepore, Vice President, Investor Relations. Please go ahead, madam.

Laura Lepore
MediPharm Labs Corp. - VP, IR

Thank you, operator, and good morning, everyone. With me on the call today are Pat McCutcheon, Chief Executive Officer; Bobby Kwon, Chief Financial Officer; Warren Everitt, Chief Executive Officer, Asia-Pacific; and Keith Strachan, our President.

Before we begin, please note the following caution respecting forward-looking statements, which is made on behalf of MediPharm Labs and all of its representatives on this call. The statements made on this call will contain forward-looking information that involves risks and uncertainties, including those introduced by the COVID-19 pandemic. Actual results could differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot